What is the equity of Chromadex this year?
Chromadex has equity of 28.46 M USD this year.
Chromadex Equity 2024
Chromadex Equity
28.46 M USD
Chromadex Dividend yield
Ticker
CDXC
ISIN
US1710774076
WKN
A2AG5N
In 2024, Chromadex's equity was 28.46 M USD, a -0.75% increase from the 28.67 M USD equity in the previous year.
Chromadex Aktienanalyse
What does Chromadex do?
The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Chromadex's Equity
Chromadex's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Chromadex's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Chromadex's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Chromadex's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Chromadex’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Chromadex Stock
What was the equity of Chromadex compared to the previous year?
The equity of Chromadex has increased/decreased by -0.75% decreased compared to the previous year.
What impact does a high equity have on investors of Chromadex?
A high equity is advantageous for investors of Chromadex as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Chromadex?
A low equity can be a risk for investors of Chromadex, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Chromadex affect the company?
An increase in equity of Chromadex can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Chromadex affect the company?
A reduction in equity of Chromadex can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Chromadex?
Some factors that can affect the equity of Chromadex include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Chromadex so important for investors?
The equity of Chromadex is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Chromadex take to change the equity?
To change equity, Chromadex can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Chromadex pay?
Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.
What is the dividend yield of Chromadex?
The current dividend yield of Chromadex is .
When does Chromadex pay dividends?
Chromadex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Chromadex?
Chromadex paid dividends every year for the past 0 years.
What is the dividend of Chromadex?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Chromadex located?
Chromadex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Chromadex from 4/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/16/2024.
When did Chromadex pay the last dividend?
The last dividend was paid out on 4/16/2024.
What was the dividend of Chromadex in the year 2023?
In the year 2023, Chromadex distributed 0 USD as dividends.
In which currency does Chromadex pay out the dividend?
The dividends of Chromadex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Chromadex stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Chromadex
Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
